KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1

Abstract

BackgroundVariable expressivity and incomplete penetrance between individuals with identical long QT syndrome (LQTS) causative mutations largely remain unexplained. Founder populations provide a unique opportunity to explore modifying genetic effects. We examined the role of a novel synonymous KCNQ1 p.L353L variant on the splicing of exon 8 and on heart rate corrected QT interval (QTc) in a population known to have a pathogenic LQTS type 1 (LQTS1) causative mutation, p.V205M, in KCNQ1-encoded Kv7.1.Methods419 adults were genotyped for p.V205M, p.L353L and a previously described QTc modifier (KCNH2-p.K897T). Adjusted linear regression determined the effect of each variant on QTc, alone and in combination. In addition, peripheral blood RNA was extracted from three controls and three p.L353L-positive individuals. The mutant transcript levels were assessed via qPCR and normalised to overall KCNQ1 transcript levels to assess the effect on splicing.ResultsFor women and men, respectively, p.L353L alone conferred a 10.0 (p=0.064) ms and 14.0 (p=0.014) ms increase in QTc and in men only a significant interaction effect in combination with the p.V205M (34.6 ms, p=0.003) resulting in a QTc of ∼500 ms. The mechanism of p.L353L's effect was attributed to approximately threefold increase in exon 8 exclusion resulting in ∼25% mutant transcripts of the total KCNQ1 transcript levels.ConclusionsOur results provide the first evidence that synonymous variants outside the canonical splice sites in KCNQ1 can alter splicing and clinically impact phenotype. Through this mechanism, we identified that p.L353L can precipitate QT prolongation by itself and produce a clinically relevant interactive effect in conjunction with other LQTS variants.

A computational model of induced pluripotent stem-cell derived cardiomyocytes for high throughput risk stratification of KCNQ1 genetic variants

“…The incomplete penetrance of the L187P mutations may be due to additional gene modifiers, environmental factors, or other patient-to-patient variations which protect against or promote the LQT phenotype in some family members. Prior studies have shown that LQT mutations often show incomplete penetrance [ 54 , 55 ], and additional gene modifiers can amplify potentially pathogenic mutants [ 56 – 59 ].…”

Indigenous Genomic Databases: Pragmatic Considerations and Cultural Contexts

“…In British Columbia (BC), Canada, cooperative efforts in research exploring the elevated prevalence of sudden cardiac death in members of the Gitxsan First Nation led to identification of a genetic variant that confers an increased susceptibility to arrhythmia and sudden death, the Long Q-T syndrome (6). Following this discovery, effective diagnosis and medical care for the affected Gitxsan community members could then be possible alongside further research to understand the complexities of the condition (7,8). In New Zealand, research on gout has been conducted in consultation and collaboration with the Māori tribe, Ngāti Porou, via its health provider, the Ngāti Porou Hauora Charitable Trust (9).…”

Expression of Imprinted Genes Kcnq1 and Cdkn1c During the Course of Differentiation from Mouse Embryonic Stem Cells into Islet-like Cells in vitro

“…Cell cycle regulation depends on the activation of CDK, and the cyclin is a positive regulator of the CDK, which is able to increase the CDK activity. Thus, the Cdkn1c protein has a limited role in regulating cell cycle progression through concerted cell cycle proteins regulation of CDK activity, affecting the cell cycle conversion [9]. It is reported that Cdkn1c protein can promote the cell apoptosis, induce differentiation and play a unique role in embryonic development.…”